Thiourea derivatives as glutaminyl cyclase inhibitors
申请人:Probiodrug AG
公开号:EP2865670A1
公开(公告)日:2015-04-29
The present invention relates to compounds of formula (I), combinations and uses thereof for disease therapy,
or a pharmaceutically acceptable salt, solvate or polymorph thereof, including all tautomers and stereoisomers thereof wherein:
A represents
and B, R1, R2, R3, R4, R5, R6 and Z are as defined throughout the description and the claims.
本发明涉及用于疾病治疗的式 (I) 化合物、其组合物和用途、
或其药学上可接受的盐、溶液或多晶型,包括其所有同系物和立体异构体 其中
A 代表
和 B、R1、R2、R3、R4、R5、R6 和 Z 在整个描述和权利要求中的定义。
WO2008/128985
申请人:——
公开号:——
公开(公告)日:——
NITROVINYL-DIAMINE DERIVATIVES AS GLUTAMINYL CYCLASE INHIBITORS
申请人:Probiodrug AG
公开号:EP2142513B1
公开(公告)日:2014-03-12
NITROVINYL-DIAMINE DERIVATIVES AS GLUTAMINYL CYCLASE INHIBITORS
申请人:Probiodrug AG
公开号:EP2142513A1
公开(公告)日:2010-01-13
THIOUREA DERIVATIVES AS GLUTAMINYL CYCLASE INHIBITORS